Detalhe da pesquisa
1.
Modified mRNA Vaccines Protect against Zika Virus Infection.
Cell;
168(6): 1114-1125.e10, 2017 03 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28222903
2.
Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.
Cell;
170(2): 273-283.e12, 2017 Jul 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28708997
3.
Structural Basis of Zika Virus-Specific Antibody Protection.
Cell;
166(4): 1016-1027, 2016 Aug 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27475895
4.
Modified mRNA Vaccines Protect against Zika Virus Infection.
Cell;
169(1): 176, 2017 03 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28340344
5.
prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.
Proc Natl Acad Sci U S A;
120(3): e2218899120, 2023 01 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36638211
6.
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination.
Nature;
543(7644): 248-251, 2017 03 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28151488
7.
Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera.
J Virol;
95(23): e0095621, 2021 11 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34549976
8.
Levels of Circulating NS1 Impact West Nile Virus Spread to the Brain.
J Virol;
95(20): e0084421, 2021 09 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34346770
9.
A CRISPR screen defines a signal peptide processing pathway required by flaviviruses.
Nature;
535(7610): 164-8, 2016 07 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27383988
10.
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans.
J Infect Dis;
224(9): 1550-1555, 2021 11 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33961055
11.
Non-structural protein 1-specific antibodies directed against Zika virus in humans mediate antibody-dependent cellular cytotoxicity.
Immunology;
164(2): 386-397, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34056709
12.
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.
JAMA;
323(14): 1369-1377, 2020 04 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32286643
13.
Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice.
J Infect Dis;
220(10): 1577-1588, 2019 10 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31260518
14.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
Lancet;
391(10120): 552-562, 2018 02 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29217376
15.
Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
J Virol;
92(18)2018 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29976679
16.
A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis.
PLoS Pathog;
13(2): e1006178, 2017 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28207910
17.
A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes.
J Infect Dis;
214(10): 1487-1491, 2016 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27655868
18.
Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly.
J Virol;
89(16): 8632-42, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26063422
19.
Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement.
PLoS Pathog;
10(4): e1004072, 2014 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24743696
20.
CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus.
J Infect Dis;
212(6): 914-23, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25754978